![lee Giguere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
lee G.
Giguere is Secretary & Chief Legal Officer at enGene Therapeutics, Inc. since 2024.
Formerly, Dr. Giguere was Secretary & Chief Legal Officer at Obsidian Therapeutics, Inc. from 2021 to 2024, Secretary, Vice President & General Counsel at Chiasma, Inc. from 2019 to 2021, Deputy General Counsel at Karyopharm Therapeutics, Inc. from 2018 to 2019, Senior Securities & Governance Counsel at Boston Scientific Corp.
from 2013 to 2016, and Head of the Business Law Department at Goodwin Procter LLP from 2006 to 2013.
Education includes undergraduate studies at Northeastern University and graduate studies at Northeastern University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Consejero General | 30/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Consejero General | 01/01/2024 |
| CHIASMA, INC. | Consejero General | 05/08/2021 |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 01/09/2019 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/09/2016 |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01/10/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Northeastern University School of Law
 Northeastern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
